Another PIPE would further lower the PPS and CNBC, et al, would not cover the stock. Do you prefer PPHM at a price considered junk and ignored by most reporting services to a $5 stock that R & R can promote through all media outlets? We all know bringing a drug to market is very expensive ( $100 Million) and our little company needs financing. Do you prefer a PIPE to what R & R can provide?
News 
Market Data 
Discover 
AI
